924P Polyfunctional HPV16-Specific T cell responses in subjects receiving PDS0101 and pembrolizumab combination treatment for recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma (HNSCC)

K.J Harrington,J Weiss,K Price,J Kaczmar,D Schaaf,N Riebel,S Jones,A Cotty,S.G Mccarthy,L.V Wood

doi:10.1016/j.annonc.2023.09.2068

924P Polyfunctional HPV16-Specific T cell responses in subjects receiving PDS0101 and pembrolizumab combination treatment for recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma (HNSCC)

K.J Harrington, J Weiss + Show 8 more

https://doi.org/10.1016/j.annonc.2023.09.2068

Copy DOI

Journal: Annals of Oncology

Publication Date: Oct 1, 2023

Affiliation: Hollings Cancer Center

#HPV16-positive Head And Neck Squamous Cell Carcinoma #Cell Responses In Subjects + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

924P Polyfunctional HPV16-Specific T cell responses in subjects receiving PDS0101 and pembrolizumab combination treatment for recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma (HNSCC)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.